Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2646-2026

RayCare 2024A SP1. Oncology Information Systems. Recall

RayCare 2024A SP1. Oncology Information Systems.

FDA recall Class II

Ongoing

FDA lists this Class II recall for RayCare 2024A SP1. Oncology Information Systems.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2646-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
May 20, 2026
FDA report date
Jul 8, 2026
Quantity in commerce
3 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

RayCare 2024A SP1. Oncology Information Systems.

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

Software Version 8.0.1.60193, UDI 0735000201083920240906, Expiration Date: 2030-01-24

View the original FDA recall notice

Why was this product recalled?

Beam set delivery note issues in which there is potential data loss if the beam set delivery note is modified simultaneously and/or if a note is updated during a treatment session, the user is not notified of the change.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did RAYSEARCH LABORATORIES AB take?

A Field Safety Notice, Medical Device Correction #175428 dated 6/2/26 was emailed to consignees. The notice advises consignees to ensure clear verbal or procedural communication when updating the beam set delivery note, avoid making changes from any location other than the control room when treatment is ongoing, avoid relying on beam set delivery note for conveying critical information. Additionally, consignees are to ensure planning staff and users are educated of the provided workaround. Consignees are to verify the software version of their units and reply to the emailed notification. A software update is scheduled for August 2026 to address this issue. Consignees with questions can contact [email protected].

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology